"Cancer Care Specialists is Northern Nevada's Choice for Oncology and Hematology care and treatment. With a combined 40 years of experience and through investments in technology and clinical excellence, we are able to ensure that our patients receive best in class care. Our physicians, nurses and staff are able to inspire hope and confidence through their patient focused approach and clinical collaboration. At Cancer Care Specialists we want to ensure that our community has access to every possible tool to treat cancer and blood disorders. As a result, we are able to deliver higher quality outcomes, and ensure a better quality of life for survivors."

During the past decade, Cancer Care Specialists - Reno conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 12 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Specialists - Reno" #1 sponsor was "SWOG Cancer Research Network" with 10 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Children's Oncology Group" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Constellation Pharmaceuticals" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Specialists - Reno" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Karyopharm Therapeutics Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Specialists - Reno" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Kidney Cancer" (2 trials). Many other conditions were trialed in "Cancer Care Specialists - Reno" in a lesser frequency.

Most popular intervention types in "Cancer Care Specialists - Reno" are "Drug" (24 trials), "Other" (20 trials), "Biological" (11 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Questionnaire Administration" (6 trials), "Nivolumab" (5 trials), "Biospecimen Collection" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Specialists - Reno" are 28 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Care Specialists - Reno". undefined are not yet recruiting, 8 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Cancer Care Specialists - Reno, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Specialists - Reno, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".